Integra Lifesciences Holdings (IART) Operating Income (2016 - 2026)
Integra Lifesciences Holdings' Operating Income history spans 17 years, with the latest figure at $23.0 million for Q4 2025.
- On a quarterly basis, Operating Income fell 35.33% to $23.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$493.4 million, a 1836.48% decrease, with the full-year FY2025 number at -$493.4 million, down 1836.55% from a year prior.
- Operating Income hit $23.0 million in Q4 2025 for Integra Lifesciences Holdings, up from $11.8 million in the prior quarter.
- Over the last five years, Operating Income for IART hit a ceiling of $67.8 million in Q4 2022 and a floor of -$512.7 million in Q2 2025.
- Historically, Operating Income has averaged $4.1 million across 5 years, with a median of $33.2 million in 2021.
- Biggest five-year swings in Operating Income: surged 268.28% in 2021 and later plummeted 16825.52% in 2025.
- Tracing IART's Operating Income over 5 years: stood at $58.2 million in 2021, then grew by 16.52% to $67.8 million in 2022, then tumbled by 46.86% to $36.0 million in 2023, then fell by 1.17% to $35.6 million in 2024, then tumbled by 35.33% to $23.0 million in 2025.
- Business Quant data shows Operating Income for IART at $23.0 million in Q4 2025, $11.8 million in Q3 2025, and -$512.7 million in Q2 2025.